Cargando…
Acylation‐stimulating protein and heart failure progression in arrhythmogenic right ventricular cardiomyopathy
AIMS: Our previous studies suggested that the complement system was critical in the prognosis of arrhythmogenic right ventricular cardiomyopathy (ARVC). The acylation‐stimulating protein (ASP), generated through the alternate complement pathway, was reported to regulate lipogenesis and triglyceride...
Autores principales: | Ren, Jie, Chen, Liang, Chen, Xiao, Zhang, Ningning, Sun, Xiaogang, Song, Jiangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871714/ https://www.ncbi.nlm.nih.gov/pubmed/36316820 http://dx.doi.org/10.1002/ehf2.14218 |
Ejemplares similares
-
Plasma testosterone and arrhythmic events in male patients with arrhythmogenic right ventricular cardiomyopathy
por: Ren, Jie, et al.
Publicado: (2020) -
Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Hylind, Robyn J., et al.
Publicado: (2020) -
Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wang, Weijia, et al.
Publicado: (2022) -
Novel Risk Prediction Model to Determine Adverse Heart Failure Outcomes in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2022) -
Crosstalk between coagulation and complement activation promotes cardiac dysfunction in arrhythmogenic right ventricular cardiomyopathy
por: Ren, Jie, et al.
Publicado: (2021)